Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 55 (PPIAP55) is a human genomic pseudogene, meaning it is a nonfunctional DNA sequence with high sequence similarity to the functional gene peptidylprolyl isomerase A (PPIA)[5][1][7]. Unlike the PPIA gene, which encodes the enzyme cyclophilin A, PPIAP55 lacks the necessary sequence or regulatory elements to produce a functional protein and is currently not reported to have regulatory or biological function. Pseudogenes like PPIAP55 originate from duplication or retrotransposition events and are mostly considered nonfunctional, although a few pseudogenes related to other families can exert gene regulatory functions through RNA mechanisms; however, such roles are not described for PPIAP55[3][7]. There is no current evidence that peptidylprolyl isomerase A pseudogene 55 is a therapeutic target, biomarker, or associated with safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 55 (PPIAP55).